Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
OKUR
Stock Latest News
Company Announcements
OnKure Announces $150M Private Placement and Board Changes
19d ago
8K
OKUR
Premium
The Fly
OnKure Therapeutics to sell 26.713M shares at $4.15 in private placement
22d ago
OKUR
Premium
Ratings
OnKure Therapeutics: Positive View on OKI-219 Ahead of PIKture-1 Breast Cancer Data as Key Upside Catalyst
1M ago
OKUR
Premium
The Fly
OnKure Therapeutics price target lowered to $27 from $34 at H.C. Wainwright
1M ago
OKUR
Premium
The Fly
OnKure Therapeutics reports Q4 EPS (99c), consensus ($1.15)
1M ago
OKUR
Premium
Company Announcements
OnKure Therapeutics Advances Clinical Programs and Expands Focus
5M ago
OKUR
Premium
Ratings
Promising Prospects for OnKure Therapeutics: Buy Rating Backed by OKI-219 Developments and Strategic Expansion
5M ago
OKUR
Premium
Ratings
Strategic Delay and Diversification: OnKure Therapeutics Positioned for Growth with Buy Rating
5M ago
OKUR
Premium
Ratings
OnKure Therapeutics: Strategic Advancements and Promising Clinical Developments Drive Buy Rating
5M ago
OKUR
Premium
The Fly
OnKure Therapeutics files $200M mixed securities shelf
5M ago
OKUR
Premium
Company Announcements
OnKure Therapeutics Announces Sales Agreement with Leerink
5M ago
8K
OKUR
Premium
The Fly
OnKure Therapeutics reports Q3 EPS ($1.09), consensus ($1.20)
5M ago
OKUR
Premium
Ratings
Promising Developments in OnKure Therapeutics’ PI3Kα Mutant Breast Cancer Treatment: Analyst Recommends Buy Rating
6M ago
OKUR
Premium
Market News
VTI ETF News, 10/9/2025
6M ago
LVO
VTI
Premium
Market News
VTI ETF News, 10/8/2025
6M ago
LVO
VTI
Premium
Market News
VTI ETF News, 10/7/2025
6M ago
VTI
BCAB
Premium
Ratings
Buy Recommendation for OnKure Therapeutics Based on Strategic Development of PI3Kα Programs and Promising OKI-219 Trial Results
7M ago
OKUR
Premium
Company Announcements
OnKure Therapeutics Advances Cancer Drug Development
8M ago
OKUR
Premium
The Fly
OnKure Therapeutics reports Q2 EPS ($1.14), consensus ($1.25)
8M ago
OKUR
Premium
Ratings
OnKure Therapeutics’ Strategic Delay and Confidence in PI3Ka Inhibitor Development Supports Buy Rating
10M ago
OKUR
Premium
Company Announcements
OnKure Therapeutics Updates on PI3Kα Inhibitor Progress
10M ago
8K
OKUR
Premium
Ratings
Buy Rating for OnKure Therapeutics Driven by Promising Developments in Metastatic Breast Cancer Treatment and Strong Financial Position
11M ago
OKUR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
